Detalhe da pesquisa
1.
Two consecutive episodes of acute hepatitis C with different genotypes in a hemodialysis patient responsive to PEG-interferon monotherapy.
Clin Nephrol
; 69(4): 313-6, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18397710
2.
Cytokeratin 19 fragments: a new marker for non-small-cell lung cancer.
Clin Biochem
; 26(4): 301-4, 1993 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-7694815
3.
Value of HAMA--determination in clinical practice--an overview.
Anticancer Res
; 17(4B): 3055-8, 1997.
Artigo
em Inglês
| MEDLINE | ID: mdl-9329600
4.
Significance of tumor marker determinations in the primary therapy of ovarian cancer.
Anticancer Res
; 17(4B): 2949-51, 1997.
Artigo
em Inglês
| MEDLINE | ID: mdl-9329572
5.
Prognostic significance of squamous cell carcinoma (SCC) antigen in primary advanced and recurrent cervical carcinoma.
Anticancer Res
; 17(4B): 2959-62, 1997.
Artigo
em Inglês
| MEDLINE | ID: mdl-9329575
6.
Prognostic significance of CA125 in patients with ovarian cancer and secondary debulking surgery.
Anticancer Res
; 17(4B): 2945-7, 1997.
Artigo
em Inglês
| MEDLINE | ID: mdl-9329571
7.
CA125 based diagnosis and therapy in recurrent ovarian cancer.
Anticancer Res
; 17(4B): 3019-20, 1997.
Artigo
em Inglês
| MEDLINE | ID: mdl-9329590
8.
CA 242 in comparison with established tumour markers in colorectal, pancreatic and lung cancer.
Anticancer Res
; 19(4A): 2477-80, 1999.
Artigo
em Inglês
| MEDLINE | ID: mdl-10470177
9.
Significance of the tumour markers CA 125 II, CA 72-4, CASA and CYFRA 21-1 in ovarian carcinoma.
Anticancer Res
; 14(6B): 2743-6, 1994.
Artigo
em Inglês
| MEDLINE | ID: mdl-7532929
10.
Clinical relevance of CYFRA 21-1, TPA-IRMA and TPA-LIA-mat in urinary bladder cancer.
Anticancer Res
; 16(6B): 3793-8, 1996.
Artigo
em Inglês
| MEDLINE | ID: mdl-9042259
11.
Nuclear mitotic apparatus protein (NuMA) in benign and malignant diseases.
Anticancer Res
; 19(4A): 2415-20, 1999.
Artigo
em Inglês
| MEDLINE | ID: mdl-10470168
12.
BTA-TRAK--a useful diagnostic tool in urinary bladder cancer?
Anticancer Res
; 19(4A): 2615-9, 1999.
Artigo
em Inglês
| MEDLINE | ID: mdl-10470204
13.
Prognostic significance of CA 125 and TPS levels after chemotherapy in ovarian cancer patients.
Anticancer Res
; 19(4A): 2523-6, 1999.
Artigo
em Inglês
| MEDLINE | ID: mdl-10470187
14.
Serum levels of CA 125 and TPS during treatment of ovarian cancer.
Anticancer Res
; 20(6D): 5107-8, 2000.
Artigo
em Inglês
| MEDLINE | ID: mdl-11326677
15.
Comparison of CYFRA 21-1, TPA and TPS in lung cancer, urinary bladder cancer and benign diseases.
Int J Biol Markers
; 9(2): 82-8, 1994.
Artigo
em Inglês
| MEDLINE | ID: mdl-7523546
16.
Methodological and clinical evaluation of two automated enzymatic immunoassays as compared with a radioimmunoassay for neuron-specific enolase.
Eur J Clin Chem Clin Biochem
; 34(8): 679-82, 1996 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-8877347
17.
Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and tissue polypeptide specific antigen (TPS) as tumour markers in lung cancer.
Eur J Clin Chem Clin Biochem
; 31(10): 689-94, 1993 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-7507359
18.
CYFRA 21-1. A new marker in lung cancer.
Cancer
; 72(3): 707-13, 1993 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-7687515
19.
Clinical significance of the tumour markers CA 125 II and CA 72-4 in ovarian carcinoma.
Int J Cancer
; 69(4): 329-34, 1996 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-8797878
20.
Prognostic significance of CA 125 and TPS levels after 3 chemotherapy courses in ovarian cancer patients.
Gynecol Oncol
; 79(3): 444-50, 2000 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-11104617